Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $713.62 billion, total revenue of $163.74 billion and a weighted average PE ratio of 47.15.
Market Cap
713.62B
Revenue
163.74B
Profits
15.14B
PE Ratio
47.15
Profit Margin
9.24%
Dividend Yield
0.20%
51 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | TMO | Thermo Fisher Scientific Inc. | 202.47B | -0.55% | 2,153,227 | 43.21B |
2 | DHR | Danaher Corporation | 146.76B | -1.82% | 5,089,772 | 24.01B |
3 | IDXX | IDEXX Laboratories, Inc. | 50.40B | 0.42% | 521,378 | 4.04B |
4 | A | Agilent Technologies, Inc. | 39.92B | 1.62% | 1,698,819 | 6.79B |
5 | IQV | IQVIA Holdings Inc. | 34.10B | -0.13% | 1,073,652 | 15.70B |
6 | MTD | Mettler-Toledo International Inc. | 27.37B | 1.48% | 123,332 | 3.87B |
7 | NTRA | Natera, Inc. | 23.62B | 2.11% | 946,516 | 1.96B |
8 | LH | Labcorp Holdings Inc. | 23.06B | -0.75% | 575,374 | 13.48B |
9 | DGX | Quest Diagnostics Incorporated | 20.23B | -0.55% | 745,336 | 10.52B |
10 | WAT | Waters Corporation | 19.50B | 2.92% | 603,923 | 3.05B |
11 | ILMN | Illumina, Inc. | 15.04B | 1.14% | 1,231,036 | 4.28B |
12 | MEDP | Medpace Holdings, Inc. | 14.92B | -0.16% | 204,450 | 2.23B |
13 | ICLR | ICON Public Limited Company | 14.50B | -0.09% | 1,169,939 | 8.09B |
14 | EXAS | Exact Sciences Corporation | 11.23B | 2.72% | 2,223,879 | 2.94B |
15 | RVTY | Revvity, Inc. | 10.65B | 0.64% | 961,751 | 2.80B |
16 | QGEN | Qiagen N.V. | 10.36B | 2.05% | 1,179,297 | 2.04B |
17 | CRL | Charles River Laboratories International, Inc. | 8.54B | 1.98% | 917,775 | 4.03B |
18 | GH | Guardant Health, Inc. | 8.15B | 2.96% | 1,594,533 | 828.85M |
19 | RDNT | RadNet, Inc. | 5.85B | -2.35% | 570,447 | 1.91B |
20 | SHC | Sotera Health Company | 4.54B | -0.50% | 1,003,435 | 1.12B |
21 | WGS | GeneDx Holdings Corp. | 3.52B | 1.60% | 397,553 | 362.32M |
22 | HTFL | HeartFlow, Inc. | 2.99B | 2.20% | 383,442 | 148.54M |
23 | VCYT | Veracyte, Inc. | 2.76B | 1.44% | 852,154 | 479.13M |
24 | GRAL | GRAIL, Inc. | 2.62B | 15.87% | 1,210,692 | 134.29M |
25 | TWST | Twist Bioscience Corporation | 1.98B | 5.37% | 2,439,943 | 362.27M |
26 | NEOG | Neogen Corporation | 1.26B | 4.11% | 6,954,595 | 894.66M |
27 | OPK | OPKO Health, Inc. | 1.23B | 0.65% | 1,781,212 | 664.03M |
28 | NEO | NeoGenomics, Inc. | 1.18B | 1.55% | 4,228,697 | 689.19M |
29 | CDNA | CareDx, Inc | 787.23M | 0.82% | 997,863 | 340.83M |
30 | PSNL | Personalis, Inc. | 769.72M | 14.66% | 1,654,523 | 80.32M |
31 | MYGN | Myriad Genetics, Inc. | 709.93M | 1.33% | 929,626 | 832.90M |
32 | FLGT | Fulgent Genetics, Inc. | 698.80M | 0.88% | 154,305 | 303.22M |
33 | CSTL | Castle Biosciences, Inc. | 684.31M | 2.92% | 242,890 | 346.27M |
34 | XGN | Exagen Inc. | 241.60M | 0.18% | 105,485 | 58.86M |
35 | MDXH | MDxHealth SA | 223.73M | -5.04% | 112,056 | 98.95M |
36 | PRE | Prenetics Global Limited | 193.03M | 2.99% | 86,976 | 57.05M |
37 | IMDX | Insight Molecular Diagnostics Inc. | 105.32M | - | 21,437 | 4.26M |
38 | FONR | FONAR Corporation | 99.04M | -1.01% | 9,803 | 104.35M |
39 | BNR | Burning Rock Biotech Limited | 95.82M | -1.22% | 7,506 | 74.86M |
40 | BDSX | Biodesix, Inc. | 60.45M | 6.16% | 46,796 | 76.56M |
41 | NOTV | Inotiv, Inc. | 52.22M | 9.35% | 225,283 | 505.30M |
42 | STRR | Star Equity Holdings, Inc. | 38.99M | -4.79% | 24,584 | 137.86M |
43 | PRPO | Precipio, Inc. | 29.72M | -2.13% | 47,781 | 21.24M |
44 | PRPH | ProPhase Labs, Inc. | 21.41M | -15.20% | 1,939,426 | 5.59M |
45 | CHEK | Check-Cap Ltd. | 12.52M | 0.47% | 132,872 | - |
46 | ADVB | Advanced Biomed Inc. | 10.16M | -1.37% | 1,283,191 | - |
47 | MYNZ | Mainz Biomed N.V. | 6.55M | -3.03% | 6,736,191 | 659.94K |
48 | XWEL | XWELL, Inc. | 5.74M | 0.83% | 24,324 | 30.60M |
49 | ISPC | iSpecimen Inc. | 5.52M | 3.02% | 677,855 | 5.91M |
50 | NDRA | ENDRA Life Sciences Inc. | 4.86M | 2.54% | 70,194 | - |
51 | BIAF | bioAffinity Technologies, Inc. | 2.98M | 24.49% | 35,044,268 | 7.68M |